SCHEMBL4447031

SCHEMBL4447031

COCCNCCC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27277009 0.82 KDM4E (0.46)
SCHEMBL11119 0.81
Formic Acid SCHEMBL1832326 0.79 ALDH1A1 (0.40)
SCHEMBL3318576 0.78 ADH1B (0.44)
SCHEMBL29060211 0.78
Fluoride SCHEMBL25246136 0.78 KDM4E (0.42)
Iodide SCHEMBL1835511 0.78 KDM4E (0.42)
SCHEMBL7790112 0.78 KDM4E (0.42)
Hydrogen Sulfide SCHEMBL3631297 0.78 KDM4E (0.42)
SCHEMBL3631301 0.78 KDM4E (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140286943-A1 CYCLOPROPYL MODULATORS OF P2Y12 RECEPTOR AUSPEX PHARMACEUTICALS INC (US) 2014-09-25 US disclosed
US-20140179829-A1 WATER BASED EPOXY RESIN PRIMER SIKA TECHNOLOGY AG (CH) 2014-06-26 US disclosed
CN-1914182-B Quinazoline derivatives ASTRAZENECA AB 2011-09-07 CN disclosed
US-7632840-B2 Quinazoline compounds for the treatment of hyperproliferative disorders ASTRAZENECA AB (SE) 2009-12-15 US disclosed
WO-2009049098-A2 MATERIALS AND METHODS FOR REGULATING THE ACTIVITY OF PHOSPHATASES INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) 2009-04-16 WO disclosed
EP-1713781-B1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2008-11-05 EP disclosed
US-20070293490-A1 Quinazoline Derivatives ASTRAZENECA AB (SE) 2007-12-20 US disclosed
CN-1914182-A Quinazoline derivatives ASTRAZENECA AB (SE) 2007-02-14 CN disclosed
EP-1713781-A1 QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2006-10-25 EP disclosed
WO-2005075439-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2005-08-18 WO disclosed